CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR systems. Neuroscience, particularly in the study of psychiatric diseases and neurological disorders such as Alzheimer’s, has been constrained by technological and biological limitations, leaving many aspects of the brain structure and functionality largely unexplored..

芝加哥--（商业新闻短讯）--GE HealthCare（纳斯达克：GEHC）今天发布了SIGNA MAGNUS，这是一种FDA 510（k）待定的头部磁共振（MR）扫描仪，旨在探索神经科学的进步，而传统全身MR系统的性能局限性限制了神经科学的进步。神经科学，特别是在精神疾病和神经系统疾病（如阿尔茨海默氏病）的研究中，受到技术和生物学限制的限制，大脑结构和功能的许多方面在很大程度上尚未探索。。

Today, 43% of the world’s population suffer from neurological disordersii, yet only a fraction can be diagnosed by MRI, making the need to expand the neurological clinical applications of MRI critical. SIGNA MAGNUS represents GE HealthCare’s vision of our most advanced 3.0T MR imaging device, specifically designed for the highest standards of neurological and oncological research for head-only imaging.

今天，世界上43%的人口患有神经系统疾病，但只有一小部分可以通过MRI诊断，因此扩大MRI的神经系统临床应用至关重要。SIGNA MAGNUS代表了GE HealthCare对我们最先进的3.0T MR成像设备的愿景，该设备专门为最高标准的神经学和肿瘤学研究设计，用于头部成像。

SIGNA MAGNUS stands at the pinnacle of MR excellence, designed to offer detail and clarity that allows for an in-depth exploration of brain microstructure, microvasculature, and function. Through SIGNA MAGNUS, GE HealthCare will help to empower neuroscientists, neurologists, neuroradiologists and oncologists to transcend barriers, with the goal of enhancing the diagnosis, understanding, and treatment of complex diseases..

SIGNA MAGNUS站在卓越先生的巅峰，旨在提供细节和清晰度，从而可以深入探索大脑的微观结构，微血管和功能。通过SIGNA MAGNUS，GE HealthCare将帮助神经科学家、神经科医生、神经放射科医生和肿瘤学家超越障碍，以增强对复杂疾病的诊断、理解和治疗。。

'With SIGNA MAGNUS, we are not just exploring the possibility of providing the tool; we are setting new benchmarks in medical research and future clinical patient care,” said Kelly Londy, CEO, MR GE HealthCare.

“对于SIGNA MAGNUS，我们不仅仅是在探索提供该工具的可能性；GE HealthCare首席执行官凯利·隆迪（KellyLondy）表示：“我们正在为医学研究和未来临床患者护理设定新的基准。”。

“This innovation underscores our commitment to R&D and our collaborations with academia, pushing the boundaries of what's possible in MR imaging. The potential impact of SIGNA MAGNUS on patient outcomes and our understanding of the human brain is profound.'

“这项创新突显了我们对研发的承诺以及与学术界的合作，推动了MR成像的可能性。SIGNA MAGNUS对患者预后和我们对人脑的理解的潜在影响是深远的。”

This advanced system offers superior gradient performance with its HyperG gradient technology, featuring 300 mT/m and 750 T/m/s, enabling the detection of fine details that were previously unattainable. Researchers can fully utilize SIGNA MAGNUS capabilities to push the boundaries of advanced anatomical, diffusion and functional techniques, amplified by the latest deep-learning algorithms that GE HealthCare has to offer.

这种先进的系统通过其超梯度技术提供了优异的梯度性能，具有300 mT/m和750 T/m/s的特点，能够检测到以前无法获得的精细细节。研究人员可以充分利用SIGNA MAGNUS的功能，推动先进的解剖，扩散和功能技术的界限，并通过GE HealthCare提供的最新深度学习算法进行扩展。

SIGNA MAGNUS is designed to be a gateway to new research opportunities, helping to uncover new parameters and biomarkers with its vast potential. Its innovative asymmetric gradient design allows for remarkable diffusion performance, achieving extremely high B-value diffusion with short echo times (TEs), which further refines the understanding of neural architecture.

SIGNA MAGNUS旨在成为新研究机会的门户，帮助发现具有巨大潜力的新参数和生物标志物。其创新的不对称梯度设计具有出色的扩散性能，实现了极高的B值扩散，回波时间短（TEs），这进一步完善了对神经结构的理解。

Additionally, many GE HealthCare 3.0T systems are upgradable to SIGNA MAGNUS, which will help potential customers to save on capital costs..

此外，许多GE HealthCare 3.0T系统都可以升级到SIGNA MAGNUS，这将有助于潜在客户节省资金成本。。

In March 2024, the investigational MAGNUS system was successfully installed at Brigham and Women’s Hospital, a leading research institution. The Brigham team will play a crucial collaborative role in performing research on high-performance neuro MR with GE HealthCare. “With this system, we will be able to measure things that weren’t possible with conventional MRI,” said Carl-Fredrik Westin, PhD, the project’s principal investigator, who is also founding director of the Laboratory of Mathematics in Imaging and director of the Neuroimaging Analysis Center in the Department of Radiology.

2024年3月，研究性MAGNUS系统成功安装在领先的研究机构Brigham and Women's Hospital。Brigham团队将在与GE HealthCare进行高性能神经MR研究方面发挥关键的合作作用。该项目的首席研究员卡尔·弗雷德里克·威斯汀博士（CarlFredrikWestin）说：“有了这个系统，我们将能够测量常规MRI无法测量的东西。”他也是影像数学实验室的创始主任和放射科神经影像分析中心的主任。

“We can ask questions we couldn’t ask before.”.

“我们可以提出以前无法提出的问题。”。

By fostering a rich environment of innovation and collaboration, GE HealthCare continues to lead in transforming the landscape of medical research and healthcare delivery, with the aim of ensuring that every scientific advancement translates into meaningful health outcomes for patients worldwide.

通过营造丰富的创新与合作环境，GE HealthCare继续引领医学研究和医疗保健服务领域的变革，旨在确保每一项科学进步都能为全球患者带来有意义的健康成果。

Learn more about SIGNA MAGNUS at the International Society for Magnetic Resonance in Medicine (ISMRM) Annual Meeting, taking place from May 4-9, 2024, in Singapore, or online here: gehealthcare.com.

在2024年5月4日至9日于新加坡举行的国际医学磁共振学会（ISMRM）年会上了解有关SIGNA MAGNUS的更多信息，或在线访问：gehealthcare.com。

About GE HealthCare Technologies Inc.

关于GE HealthCare Technologies Inc。

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier.

GE HealthCare是全球领先的医疗技术、药物诊断和数字解决方案创新者，致力于提供集成的解决方案、服务和数据分析，使医院更高效、临床医生更有效、治疗更精确，患者更健康、更快乐。

Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring.

GE HealthCare为患者和提供者服务了125多年，正在推进个性化、互联化和富有同情心的护理，同时简化患者跨越护理路径的旅程。我们的成像、超声波、患者护理解决方案和药物诊断业务共同帮助改善患者护理，从诊断到治疗再到监测。

We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits..

我们是一家价值196亿美元的企业，拥有约51000名员工，致力于创造一个医疗保健无限的世界。